Marshall Wace North America L.P. - GOSSAMER BIO INC ownership

GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 128 filers reported holding GOSSAMER BIO INC in Q3 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of GOSSAMER BIO INC
ValueSharesWeighting
Q3 2021$10,567,000
+54.8%
840,6420.0%0.04%
+55.2%
Q2 2021$6,826,000
-12.2%
840,6420.0%0.03%
-9.4%
Q1 2021$7,776,000
-6.0%
840,642
-1.8%
0.03%
-15.8%
Q4 2020$8,274,000
-20.7%
855,641
+1.8%
0.04%
-43.3%
Q3 2020$10,432,000
+80.9%
840,642
+223.3%
0.07%
+86.1%
Q2 2019$5,767,000
-39.4%
260,010
-40.8%
0.04%
+5.9%
Q1 2019$9,523,000439,4610.03%
Other shareholders
GOSSAMER BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 3,370,000$4,044,0000.97%
Octagon Capital Advisors LP 3,958,069$4,749,6830.66%
Palo Alto Investors LP 3,465,152$4,158,1820.34%
NEA Management Company, LLC 3,467,406$4,160,8870.32%
APIS CAPITAL ADVISORS, LLC 180,000$216,0000.22%
Boxer Capital, LLC 3,336,928$4,0040.19%
HHLR ADVISORS, LTD. 4,974,041$5,968,8490.13%
Artal Group S.A. 3,028,171$3,6340.11%
PLATINUM INVESTMENT MANAGEMENT LTD 2,363,170$2,835,8040.10%
Birchview Capital, LP 99,088$118,9060.09%
View complete list of GOSSAMER BIO INC shareholders